Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2026 · 10-Q
Revenue$2.61M$2.61M−24.9% vs Q3 2025 Net Income$2.37M$2.37M+774.3% vs Q3 2025 EPS Diluted$0.16$0.16+700.0% vs Q3 2025 Operating Income-$419,263N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$280,983+815.4% Margins · derivedOperating margin-16.1%−24.0 pt vs Q3 2025
Net margin91.0%+83.2 pt vs Q3 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end